Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: stillpoint21
2
Nov 02, 2007 02:23PM

Please read again

From the date hereof until the termination of the Commercialization Agreement, neither Patriot nor any of its Representatives shall take any action with respect to those matters concerning which TPL is authorized to act on behalf of the parties pursuant to the Commercialization Agreement and the Grant referred to therein, including, but not limited to, contacting, pursuing litigation against, or entering into discussions or negotiations with potential infringers, entering into license agreements, settlement agreements, or other similar agreements with respect to the MSD Patents, or selling or otherwise transferring any interest in the MSD Patents.

 

This means that TPL can SELL or TRANSFER either PDS or the rights managed by PDS subject to both PTSC and TPL receiving 50% each of the proceeds. There is no rewrite of the contract, nor any reason to put the matter to shareholders. The variation would relate to the purchaser retaining all subsequent licensing fees.

 

 

 

Be well

1
Nov 02, 2007 05:43PM

Nov 02, 2007 06:05PM
Share
New Message
Please login to post a reply